SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Revenue for the quarter ended  March 2022 of Rs. 5835.76 millions grew by 19.04 % from Rs. 4902.51 millions.The Net Profit of the company registered a slight decline of -19.30% to Rs. 827.19  millions from Rs. 1025.07 millions.The Operating Profit of the company witnessed a decrease to 1234.39 millions from 1511.74 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 5835.76 4902.51 19.04 21898.76 18919.95 15.74 21898.76 18919.95 15.74
Other Income 18.56 253.04 -92.67 386.14 1118.89 -65.49 386.14 1118.89 -65.49
PBIDT 1234.39 1511.74 -18.35 5475.24 6682.54 -18.07 5475.24 6682.54 -18.07
Interest 15.77 6.83 130.89 49.49 71.92 -31.19 49.49 71.92 -31.19
PBDT 1218.62 1504.91 -19.02 5425.75 6610.62 -17.92 5425.75 6610.62 -17.92
Depreciation 217.86 161.92 34.55 712.82 673.55 5.83 712.82 673.55 5.83
PBT 1000.76 1342.99 -25.48 4712.93 5937.07 -20.62 4712.93 5937.07 -20.62
TAX 173.57 317.92 -45.40 1102.91 1466.23 -24.78 1102.91 1466.23 -24.78
Deferred Tax -136.43 32.92 -514.43 -122.09 91.23 -233.83 -122.09 91.23 -233.83
PAT 827.19 1025.07 -19.30 3610.02 4470.84 -19.25 3610.02 4470.84 -19.25
Equity 154.56 154.56 0.00 154.56 154.56 0.00 154.56 154.56 0.00
PBIDTM(%) 21.15 30.84 -31.40 25.00 35.32 -29.21 25.00 35.32 -29.21

JB Chem & Pharma Share Price

1997.35 22.65 (1.15%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×